Concord Medical Co., Ltd. (TPEX:6518)
Taiwan · Delayed Price · Currency is TWD 30.15
0.00 (0.00%)
Oct 29, 2026, 12:31 PM CST
Concord Medical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,038 | 964.35 | 889.85 | 833.2 | 889.21 | 738.99 |
Revenue Growth | 7.69% | 8.37% | 6.80% | -6.30% | 20.33% | -8.73% |
Gross Profit Gross Profit Growth | 147.33 | 133.96 | 109.62 | 102.15 | 109.1 | 68.49 |
Operating Income Operating Income Growth | 68.99 | 72.78 | 60.81 | 54.74 | 64.78 | 37.47 |
Net Income Net Income Growth | 85.79 | 67.36 | 49.57 | 42.74 | 50.66 | 34.4 |
Earnings Per Share EPS Growth | 2.55 | 2.01 | 1.48 | 1.28 | 1.52 | 1.37 |
EPS Growth | 26.82% | 35.81% | 15.63% | -15.77% | 10.93% | 73.42% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 225.93 | 283.18 | 321.25 | 320.26 | 346.91 | 198.8 |
Total Debt Total Debt Growth | 179.94 | 178.42 | 201.87 | 206.68 | 180.92 | 190.16 |
Net Cash (Debt) Net Cash Growth | 45.99 | 104.76 | 119.37 | 113.58 | 165.99 | 8.64 |
Net Cash Growth | -56.10% | -12.24% | 5.10% | -31.57% | 1822.12% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.37 | 3.13 | 3.57 | 3.40 | 4.97 | 0.34 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 131.26 | 157.24 | 148.83 | 113.23 | 154.56 | 137.42 |
Capital Expenditures CapEx Growth | -2.62 | -33.82 | -74.72 | -88.18 | -37.46 | -21.8 |
Free Cash Flow Free Cash Flow Growth | 128.64 | 123.42 | 74.12 | 25.05 | 117.1 | 115.63 |
Free Cash Flow Growth | 4.23% | 66.52% | 195.91% | -78.61% | 1.27% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.19% | 13.89% | 12.32% | 12.26% | 12.27% | 9.27% |
Operating Margin | 6.64% | 7.55% | 6.83% | 6.57% | 7.29% | 5.07% |
Pretax Margin | 9.73% | 8.59% | 7.02% | 6.54% | 7.22% | 5.79% |
Profit Margin | 8.26% | 6.98% | 5.57% | 5.13% | 5.70% | 4.66% |
FCF Margin | 12.39% | 12.80% | 8.33% | 3.01% | 13.17% | 15.65% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.500 | 1.500 | 1.100 | 1.000 | 1.000 | 0.500 |
Dividend Per Share Growth | 36.36% | 36.36% | 10.00% | 0% | 100.00% | 25.00% |
Dividend Yield | 4.97% | 5.73% | 4.26% | 3.91% | 4.24% | 3.70% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.83 | 12.96 | 17.35 | 19.96 | 15.53 | 13.08 |
P/FCF Ratio | 7.81 | 7.08 | 11.60 | 34.07 | 6.72 | 3.89 |
PS Ratio | 0.97 | 0.91 | 0.97 | 1.02 | 0.89 | 0.61 |